A citation-based method for searching scientific literature

Karina L Brierley, Erica Blouch, Whitney Cogswell, Jeanne P Homer, Debbie Pencarinha, Christine L Stanislaw, Ellen T Matloff. Cancer J 2012
Times Cited: 62







List of co-cited articles
258 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Obstetrics/gynecology residents' knowledge of hereditary breast and ovarian cancer and Lynch syndrome.
Kaylene J Ready, Molly S Daniels, Charlotte C Sun, Susan K Peterson, Hope Northrup, Karen H Lu. J Cancer Educ 2010
13
23



Physicians' knowledge of genetics and genetic tests.
K J Hofman, E S Tambor, G A Chase, G Geller, R R Faden, N A Holtzman. Acad Med 1993
126
4



The "duty to warn" a patient's family members about hereditary disease risks.
Kenneth Offit, Elizabeth Groeger, Sam Turner, Eve A Wadsworth, Mary A Weiser. JAMA 2004
146
4


Earlier age of onset of BRCA mutation-related cancers in subsequent generations.
Jennifer K Litton, Kaylene Ready, Huiqin Chen, Angelica Gutierrez-Barrera, Carol J Etzel, Funda Meric-Bernstam, Ana M Gonzalez-Angulo, Huong Le-Petross, Karen Lu, Gabriel N Hortobagyi,[...]. Cancer 2012
44
6

Physician use of genetic testing for cancer susceptibility: results of a national survey.
Louise Wideroff, Andrew N Freedman, Lorayn Olson, Carrie N Klabunde, William Davis, Kadaba P Srinath, Robert T Croyle, Rachel Ballard-Barbash. Cancer Epidemiol Biomarkers Prev 2003
91
4


Educational needs and preferred methods of learning among Florida practitioners who order genetic testing for hereditary breast and ovarian cancer.
Deborah Cragun, Andrea Doty Besharat, Courtney Lewis, Susan T Vadaparampil, Tuya Pal. J Cancer Educ 2013
12
25

Acceptability of telemedicine and other cancer genetic counseling models of service delivery in geographically remote settings.
Eileen McDonald, Amanda Lamb, Barbara Grillo, Lee Lucas, Susan Miesfeldt. J Genet Couns 2014
26
11


Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results.
A R Bradbury, L Patrick-Miller, D Fetzer, B Egleston, S A Cummings, A Forman, L Bealin, C Peterson, M Corbman, J O'Connell,[...]. Clin Genet 2011
28
10

Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction.
L Baumanis, J P Evans, N Callanan, L R Susswein. J Genet Couns 2009
48
6

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Donald A Berry, Edwin S Iversen, Daniel F Gudbjartsson, Elaine H Hiller, Judy E Garber, Beth N Peshkin, Caryn Lerman, Patrice Watson, Henry T Lynch, Susan G Hilsenbeck,[...]. J Clin Oncol 2002
299
4

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
Elena Castro, Chee Goh, David Olmos, Ed Saunders, Daniel Leongamornlert, Malgorzata Tymrakiewicz, Nadiya Mahmud, Tokhir Dadaev, Koveela Govindasami, Michelle Guy,[...]. J Clin Oncol 2013
337
4

Lifetime cancer risks in individuals with germline PTEN mutations.
Min-Han Tan, Jessica L Mester, Joanne Ngeow, Lisa A Rybicki, Mohammed S Orloff, Charis Eng. Clin Cancer Res 2012
388
4

The use of telephone in genetic counseling versus in-person counseling: a randomized study on counselees' outcome.
Ulla Platten, Johanna Rantala, Annika Lindblom, Yvonne Brandberg, Gunilla Lindgren, Brita Arver. Fam Cancer 2012
26
11

Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
Joël Vos, Encarna Gómez-García, Jan C Oosterwijk, Fred H Menko, Reinoud D Stoel, Christi J van Asperen, Anna M Jansen, Anne M Stiggelbout, Aad Tibben. Psychooncology 2012
45
6

Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
J O Culver, C D Brinkerhoff, J Clague, K Yang, K E Singh, S R Sand, J N Weitzel. Clin Genet 2013
53
5


The Angelina effect: immediate reach, grasp, and impact of going public.
Dina L G Borzekowski, Yue Guan, Katherine C Smith, Lori H Erby, Debra L Roter. Genet Med 2014
88
4

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
237
4

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.
Holly LaDuca, A J Stuenkel, Jill S Dolinsky, Steven Keiles, Stephany Tandy, Tina Pesaran, Elaine Chen, Chia-Ling Gau, Erika Palmaer, Kamelia Shoaepour,[...]. Genet Med 2014
200
4

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.
Karen H Lu, Marie E Wood, Molly Daniels, Cathy Burke, James Ford, Noah D Kauff, Wendy Kohlmann, Noralane M Lindor, Therese M Mulvey, Linda Robinson,[...]. J Clin Oncol 2014
133
4

Models of service delivery for cancer genetic risk assessment and counseling.
Angela M Trepanier, Dawn C Allain. J Genet Couns 2014
42
7

Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance.
Adam H Buchanan, Santanu K Datta, Celette Sugg Skinner, Gail P Hollowell, Henry F Beresford, Thomas Freeland, Benjamin Rogers, John Boling, P Kelly Marcom, Martha B Adams. J Genet Couns 2015
69
4

Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
Terri Febbraro, Katina Robison, Jennifer Scalia Wilbur, Jessica Laprise, Amy Bregar, Vrishali Lopes, Robert Legare, Ashley Stuckey. Gynecol Oncol 2015
58
5

Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
Mary-Claire King, Ephrat Levy-Lahad, Amnon Lahad. JAMA 2014
163
4

Direct to confusion: lessons learned from marketing BRCA testing.
Ellen Matloff, Arthur Caplan. Am J Bioeth 2008
45
6

National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
122
4

Massively parallel sequencing: the next big thing in genetic medicine.
Tracy Tucker, Marco Marra, Jan M Friedman. Am J Hum Genet 2009
176
3

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Chanita Hughes Halbert, Tiffani DeMarco, William Lawrence, David Main, Clinton Finch, Colette Magnant,[...]. J Clin Oncol 2004
179
3

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
3

Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test results.
J Vos, J C Oosterwijk, E Gómez-García, F H Menko, A M Jansen, R D Stoel, C J van Asperen, A Tibben, A M Stiggelbout. Clin Genet 2011
31
6

Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
Marc D Schwartz, Claudine Isaacs, Kristi D Graves, Elizabeth Poggi, Beth N Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L Taylor, Lauren Perley. Cancer 2012
86
3

Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
Noah D Kauff, Nandita Mitra, Mark E Robson, Karen E Hurley, Shaokun Chuai, Deborah Goldfrank, Eve Wadsworth, Johanna Lee, Tessa Cigler, Patrick I Borgen,[...]. J Natl Cancer Inst 2005
44
4

Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis.
Jeffrey N Weitzel, Sarah M McCaffrey, Raluca Nedelcu, Deborah J MacDonald, Kathleen R Blazer, Carey A Cullinane. Arch Surg 2003
109
3

Genetic variants of uncertain significance: flies in the ointment.
Susan Domchek, Barbara L Weber. J Clin Oncol 2008
29
6

A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.
Douglas F Easton, Amie M Deffenbaugh, Dmitry Pruss, Cynthia Frye, Richard J Wenstrup, Kristina Allen-Brady, Sean V Tavtigian, Alvaro N A Monteiro, Edwin S Iversen, Fergus J Couch,[...]. Am J Hum Genet 2007
292
3


Prevention and management of hereditary breast cancer.
Steven A Narod, Kenneth Offit. J Clin Oncol 2005
98
3


Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers.
S U Dhar, H P Cooper, T Wang, B Parks, S A Staggs, S Hilsenbeck, S E Plon. Breast Cancer Res Treat 2011
21
9

The use and interpretation of commercial APC gene testing for familial adenomatous polyposis.
F M Giardiello, J D Brensinger, G M Petersen, M C Luce, L M Hylind, J A Bacon, S V Booker, R D Parker, S R Hamilton. N Engl J Med 1997
256
3


Primary care physicians' utilization and perceptions of genetics services.
S J Hayflick, M P Eiff, L Carpenter, J Steinberger. Genet Med 1998
90
3

Underdiagnosis of Lynch syndrome involves more than family history criteria.
Hardeep Singh, Rachel Schiesser, Gobind Anand, Peter A Richardson, Hashem B El-Serag. Clin Gastroenterol Hepatol 2010
46
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.